04/04/2024 | Press release | Distributed by Public on 04/04/2024 13:52
ITEM 3.02DEPARTURE OF DIRECRTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.
Election of Directors
As disclosed in Cell MedX Corp.'s (the "Company") definitive Schedule 14C information statement (the "Information Statement"), filed with the Securities and Exchange Commission on or about March 6, 2024, stockholders of the Company holding 66.0% of the outstanding shares of the Company's common stock executed written consents to elect the following persons as directors of the Company, which election became effective on or about April 1, 2024:
David Jeffs
Dr. George Adams
Joao (John) Da Costa
Amir Vahabzadeh
The information required by Item 404(a) of Regulation SK was included in the Information Statement and is incorporated by reference herein.